News
Monday 1st March 2021
Minister for Mental Health and Older People Mary Butler TD announces new public consultation on the Mental Health Act
The Minister of State for Mental Health and Older People, Mary Butler T.D., has today announced a new public consultation on the ongoing review of the Mental Health Act 2001. The public consultation will provide an opportunity for key stakeholders, including people who have used the mental health services and their families to inform the review prior to publication of draft legislation to update the Act in full.
On announcing the public consultation Minister Butler said: “Today I am pleased to announce a fresh public consultation on the ongoing review of the Mental Health Act. The voice of people who use our mental health services, and their families is of paramount importance when developing policies and legislation. While the review of the Act is based on the 2015 Expert Group report, which included a public consultation,
Johnson & Johsnon’s Covid-19 vaccine is now the third one granted FDA emergency authorization. The company expects to deliver enough vials for vaccinating more than 200 million people in the U.S. by the middle of this year.
Microgrant scheme in support of quality inclusive education in 40 schools in Romania coe.int - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from coe.int Daily Mail and Mail on Sunday newspapers.
MedCity News
Otsuka launches pivotal trial of digital therapeutics for depression
Otsuka Pharmaceutical is partnering with Click Therapeutics to launch a remote clinical trial to evaluate the effectiveness of digital therapeutics in reducing depressive symptoms.
Shares0
Otsuka Pharmaceutical is launching a virtual study to see if digital therapeutics can reduce depression symptoms.
It’s the next step in a partnership between the Tokyo-based drugmaker and Click Therapeutics, a digital health startup that is developing programs for smoking cessation, depression and insomnia.
They plan to enroll up to 540 patients in a randomized, controlled trial that will test the digital therapeutic’s efficacy in patients that are taking antidepressants. The remote trial will be conducted using Verily’s Project Baseline platform.